TruthArchive.ai - Related Video Feed

Sugar consumption has increased 400-fold since 1964, and blood sugar is the root of much illness. Alzheimer's disease is type three diabetes, or insulin resistance in the brain. The brain is crack-addicted to sugar and even secretes its own insulin. The brain will take what it needs, leaching calcium from bones or stripping amino acids from muscle. If the brain wants sugar, it activates the r f one a two receptor on the back of the tongue, which provides a dopamine release when sugar is consumed. The trick is you have to swallow.

Ten percent of 65-year-olds, 25% of 75-year-olds, and 50% of 85-year-olds will develop dementia or Alzheimer's disease. Despite spending over $2 billion on drug treatments, efforts have failed. Scientists at Brown discovered insulin resistance in the brain, likening Alzheimer's to type 3 diabetes. Poor metabolic health, often due to insulin resistance caused by excessive insulin and sugar, drives the cascade leading to Alzheimer's. Evidence of Alzheimer's can appear 30 to 40 years before symptoms arise. The typical diet, high in sugar and starch, contributes to diabetes of the brain. Understanding this allows individuals to heal their brains.

Eating sugar slows metabolism and increases hunger hormones, leading to weight gain and reduced fat burning. It creates inflammation and lowers testosterone in males, reducing sex drive and function. In women, it causes hormonal dysregulation and hippocampus shrinkage, impacting memory. Minimizing sugar intake and maximizing exercise are crucial. Supplements and stem cells are ineffective without addressing these fundamental issues.

Inflammation releases pro-inflammatory proteins, causing insulin resistance. Insulin resistance in various tissues spreads chronic disease. Hypertension, the most common cardiovascular problem, is mainly caused by insulin resistance. Alzheimer's disease is referred to as type three diabetes, or insulin resistance of the brain. Erectile dysfunction, a common form of male infertility, stems from insulin resistance in blood vessels. Polycystic ovary syndrome (PCOS), a common cause of female infertility, results from insulin resistance affecting the ovaries and sex hormone production.

Alzheimer's and dementia are actually type 3 diabetes, caused by insulin resistance in the brain. Elevated blood sugar levels for 10 years prior to diagnosis are common in early onset patients. The misconception that these diseases cause memory loss is incorrect; patients lose access to their memories, but this access can be restored. The brain consumes 45% of the carbohydrates we consume, and it will take what it needs from other sources, such as calcium from bones or amino acids from muscle tissue. The brain also activates a receptor that rewards us with dopamine for consuming sugar, leading to addiction for many.

Alzheimer's and dementia should be called type three diabetes, as they are caused by insulin resistance in the brain. The brain makes its own insulin, despite what endocrinologists say about the pancreas being the sole producer. The brain becomes addicted to sugar and will do what it takes to get it, including stripping calcium from bones or activating the r f one a two receptor for a dopamine reward. Excess sugar in the brain is stored as amyloid plaque in the neurosynaptic junctions. People with Alzheimer's are not losing their memory, but rather losing access to it due to this buildup.

Speaker 0 discusses factors associated with low blood flow in the brain, listing caffeine, nicotine, marijuana, alcohol, not sleeping, and being overweight. He states, "Caffeine constricts blood flow to the brain." He adds, "Nicotine, marijuana, alcohol, not sleeping, being overweight." He notes, "I published three studies on 33,000 people." He concludes, "As your weight goes up, the size and function of your brain goes down, which should scare the fat off anyone." The message links weight to brain size and function and identifies lifestyle factors that may affect cerebral blood flow. The speaker frames these points as factors influencing brain perfusion and brain health.

We are one of the few nations still calling Alzheimer's and dementia Type 3 diabetes. Insulin resistance in the brain, known as Type 3 diabetes, is the main cause of Alzheimer's. The myth that Alzheimer's is memory loss is false; it's actually loss of memory access, which can be restored. Look into the link between COMT gene mutation and diabetes. Insulin's main role is not to lower blood sugar, but to block other energy use in the body.

The brain is the most metabolically demanding organ, relying heavily on blood flow for cognitive function. Improved blood flow enhances cognition, while restricted blood flow impairs it. Age-related cognitive decline and dementia are sometimes called type three diabetes or diabetes of the brain. Some Alzheimer's patients find relief on ketogenic diets, which isn't a cure, but can improve brain function by improving blood flow and reducing inflammation. Inflammation depletes cognitive function, while reducing inflammation enhances it.

Eighty-seven percent of people are metabolically dysfunctional, meaning their metabolism is not working, resulting in high blood glucose and insulin, hypertension, and dysfunctional mitochondria. This leads to prediabetes/diabetes, increased body fat, hunger, fatigue, and accelerated aging. Dihydroberberine, the optimized form of berberine, is a glucose disposal agent. It is claimed to be the speaker's number one most powerful way to anti-age and protect against metabolic dysfunction.

An individual who is sleep deprived in just seven days will test for insulin resistance. So your journey from being healthy to potentially type two diabetic can be that rapid with sleep deprivation, and there's a direct correlation between the two. I was looking after 14 metabolic clinics at one stage pre COVID, and there is not one person that I consulted that was overweight or suffered from obesity that said to me, Moody, I sleep well. Every single one of them that had metabolic syndrome, had problems with weight gain, had health issues, had cholesterol issues, had type two diabetes, every single one of them had sleep problems.

Obesity is characterized by fat around the brain, neck, and heart, potentially causing sleep apnea, as well as marbled muscle mass. Visceral fat and energy problems can occur in both obese and relatively skinny individuals. A person who is 100 pounds overweight carries an extra 350,000 calories, while someone ten pounds overweight carries 35,000, but both may experience fatigue, hunger, cravings, and mental fog due to hijacked hormones. Both may have hyperinsulinemia, preventing fat burning. The location of fat storage differs, but the root cause is the same. Lowering insulin levels allows the body to burn stored fat, improving energy levels and reducing hunger. The food industry focuses on calories, but controlling blood sugar and insulin is key. A meal that doesn't spike blood sugar leads to less insulin production, putting the body in burning mode and promoting satiety, which reduces cravings and allows the body to burn stored fat.

Fatty liver disease impacts immediate health, not just long-term risks. A fatty liver fuels inflammation and disrupts metabolism, worsening insulin resistance and potentially leading to prediabetes and type 2 diabetes. Symptoms include fatigue, post-meal sluggishness, sugar cravings, mid-day energy crashes, and brain fog. It promotes belly fat storage and hinders fat loss, while also increasing chronic inflammation, damaging blood vessels, and raising blood pressure. The condition also disrupts cholesterol processing, elevating dangerous triglycerides. Fatty liver is a metabolic roadblock that can make you feel worse, burn less fat, and age faster. Early action makes reversal easier.

Insulin resistance is not just about blood sugar or body weight. It's silently damaging every system in your body, often without any symptoms at all. Elevated insulin causes your kidneys to retain sodium, and this increases overall blood volume and blood pressure. This is a direct pathway from insulin resistance to high blood pressure. What about type two diabetes? Your pancreas keeps pumping out more and more insulin to try to stabilize blood sugar, but eventually it can't keep up. Blood sugar rises and full blown diabetes sets in. Next, let's talk about cancer risk. Chronically high insulin levels raises IGF-one, which is a growth hormone.

There are two types of fat: subcutaneous fat, which is beneath the skin and not dangerous, and visceral fat, which surrounds the organs and can be very dangerous. Excess visceral fat is the number one risk factor for insulin resistance. If you have skin tags, darker skin around your neck, constant hunger, cravings, migraine headaches, mental health problems, or hormonal health problems like PCOS or erectile dysfunction, you may have insulin resistance. Eighty-six million American adults have insulin resistance. The speaker's videos address the root cause of these symptoms, which is insulin resistance.

Fatty liver disease impacts immediate health, not just long-term risks. It fuels inflammation and disrupts metabolism, worsening insulin resistance and potentially leading to prediabetes and type 2 diabetes. Symptoms include fatigue, post-meal sluggishness, sugar cravings, mid-day energy crashes, brain fog, and increased belly fat. A fatty liver gums up the metabolic engine and increases chronic inflammation, keeping the immune system in fight mode. This damages blood vessels, increases blood pressure, and disrupts cholesterol processing, raising triglycerides. Fatty liver is a metabolic roadblock that makes you feel worse, burn less fat, and age faster, and early action is key to reversing it.

ADHD, dementia, Alzheimer's, glaucoma, cavities, aging, insomnia, diabetes, cancer. Sugar affects various parts of our body, causing these conditions. It even fuels a billion-dollar industry on Wall Street. Surprisingly, addiction to sugar is eight times more potent than cocaine. It's important to recognize sugar as the true adversary.

Alzheimer's is referred to as type three diabetes, meaning insulin resistance in the brain. Our brains become highly dependent on sugar, and the brain manufactures its own insulin. The problem is that when insulin resistance occurs in the brain, unlike the body, there isn’t a stored-sugar exchange through glycogen. The body stores sugar as glycogen in the liver and muscles and can release glucose back into the bloodstream, but the brain lacks this same storage-and-release mechanism. Within the brain, there are neurosynaptic junctions—little spaces where nerve endings don’t touch, and signals jump across the gap. When these gaps fill with amyloid plaques and neurofibrillary tangles, people say that’s the genesis of Alzheimer's. However, the transcript states that the truth is the genesis of it was insulin resistance.

Ten percent of 65-year-olds, 25% of 75-year-olds, and 50% of 85-year-olds will develop dementia or Alzheimer's disease. Despite spending over $2 billion on drug treatments, there has been no success. Scientists at Brown discovered insulin resistance in the brain, likening Alzheimer's to type 3 diabetes. Poor metabolic health, often due to insulin resistance caused by excessive insulin and sugar, is a significant factor in Alzheimer's. Evidence of Alzheimer's can appear 30 to 40 years before symptoms arise. The prevalence of sugar and starch in diets contributes to diabetes of the brain. Understanding this connection can lead to brain healing.

Poor sleep isn't just about feeling tired. It's wrecking your hormones. From cortisol to ghrelin, it's raising your stress and hunger hormones throughout the day. It increases your risk of insulin resistance, anxiety, brain fog, and even heart disease. And it absolutely tanks your recovery, both physically and mentally. You crave junk, you snap more easily, and your willpower fades. If you're sleeping poorly, everything else becomes an uphill battle.

Tucker Carlson interviews Dr. Daniel Amen about cannabis, brain health, and broader public health trends. Amen cites his 1000-person marijuana study showing lower brain blood flow and activity across all examined regions in users compared with healthy controls, with measurable deficits on SPECT imaging that assess blood flow and mitochondrial function. He explains mitochondria as cellular energy producers and notes that 49% of the tracer in their imaging is taken up by brain mitochondria; thus, low activity on the scan reflects reduced mitochondrial function and blood flow. He also references a separate study from an independent group of 1000 young marijuana users showing reduced blood flow and activity in brain areas involved in learning and memory, aligning with his assertion that marijuana is not innocuous for the brain. Amen lists consequences associated with reduced mitochondrial activity and blood flow: tiredness, low motivation, depression, increased anxiety (due to brain not settling), and, in vulnerable individuals, an increased risk of psychosis. He emphasizes that the connection between heavy marijuana use and psychosis is real and notes a genetic factor: a certain gene abnormality can lead to a sevenfold increase in the risk of psychosis in heavy users, with the general risk estimated at two to four times higher, particularly when use begins in youth. He argues that younger users face more brain development disruption and cites CDC data showing alarming mental-health trends among teens, including 57% of teenage girls reporting persistent sadness, 32% having thought of suicide, 24% having planned to kill themselves, and 13% having attempted it. He suggests marijuana contributes to this “mental mess,” though he acknowledges multiple factors. Carlson pushes back on the view of cannabis as a medicine, prompting Amen to discuss how, while cannabis can help certain conditions (glaucoma, appetite stimulation), it is not universally beneficial and can increase anxiety in some users. Amen describes a “doom loop” in which pain and distress trigger automatic negative thoughts (ANTs), amplifying suffering and potentially leading to relapse or worse mental health outcomes. He argues that cannabis can blunt certain pain pathways but, when used chronically, reinforces dependence and prevents brain rehabilitation. Amen contrasts marijuana with alcohol, describing rumors of “alcohol as health food” as a societal lie, noting recent statements by the American Cancer Society against any alcohol use due to cancer risk. He recounts experiences in psychiatry since the 1980s involving changes in attitudes toward gaming, alcohol, and drug policy, arguing that stimulants and sedatives (opiates, benzodiazepines) have historically created poor outcomes. He claims marijuana industry marketing aims to minimize perceived risk and accuses the industry of funding campaigns to mislead the public, similar to tactics used by historical industry players. In discussing brain imaging, Amen highlights the cerebellum (the “little brain”) as crucial for both movement and cognitive processing. Marijuana’s effect on the cerebellum can slow thinking and impair coordination, which underpins the admonition not to drive high. He explains that cannabis acts on CB1 receptors and modulates dopamine, producing a high but potentially disrupting dopamine in vulnerable individuals, sometimes triggering psychosis. Amen stresses the need to love and protect the brain, arguing that brain health should be prioritized in public policy. He advocates for preventing brain injury, reducing toxin exposure, maintaining sleep, exercise, and a healthy diet, and he introduces the Bright Minds framework: B = Blood flow; R = Retirement and aging (learn new things); I = Inflammation; G = Genetics; H = Head trauma; T = Toxins; M = Materials (personal products); I = Immunity; N = Neurohormones; D = Diabetes; S = Sleep. He explains how each factor affects brain health and how marijuana and obesity harm the brain by decreasing blood flow and increasing inflammation. He cites a study from the University of Pittsburgh showing overweight individuals have smaller brain volumes and older-appearing brains; obese individuals show even greater reductions. He notes that marijuana use lowers testosterone and can contribute to vascular problems, including a reported 600% increased heart attack risk for those over 50 who use marijuana. On ADHD and youth, Amen describes using brain scans to differentiate toxic brains from those with genuine ADHD, emphasizing that stimulants are not the universal answer and that underlying toxicities must be addressed. He recounts a case where a child’s left temporal lobe cyst caused behavioral changes, which surgery ultimately improved after imaging revealed the physical cause. He argues for looking at brain pathology before labeling and treating, and he describes his broader mission to foster a national brain health revolution, encouraging people to ask whether their actions are good for their brain. Amen also discusses psilocybin, kratom, and other substances, acknowledging potential therapeutic uses in specific contexts (psilocybin for PTSD/depression) while warning about risks such as unbalancing effects and the lack of standardized dosing in many studies. He notes a rising trend in mushroom use among youth and increasing emergency-room visits for psilocybin-induced psychosis. He cautions about the lack of regulation for kratom and its potential to worsen brain function, presenting it as another “weapon of mass destruction” in public health discussions. Towards the end, Amen describes his clinical experiences with trauma, epigenetics, and intergenerational influences on mental health, stressing that thoughts, even disturbing ones, do not define character and can be managed through cognitive strategies such as cognitive behavioral techniques and reframing. He closes with a personal call to care for brain health, emphasizing practical steps like sleep, exercise, nutrition, vitamin D optimization, dental health, reducing toxin exposure, and mindful use of technology, including cautions about AI’s potential impact on cognitive function.